Sanofi's Genzyme recalls transplant drug after stability test failure FiercePharma Manufacturing The company, whose vaccine division has been battling mold problems at a plant in Canada, now is voluntarily recalling 9 lots of Thymoglobulin, used to treat kidney transplant rejection. The company recalled one lot Aug. 2 after it failed a stability ... Genzyme recalls transplant drug Sanofi's Genzyme Pulls 19 Lots Of Thymoglobulin Vials |
